Gilead Sciences Inc |
1,781,302 (4.9) |
241,799,108 (16.2) |
243,580,410
(16.0) |
AbbVie, Inc |
1,701,140 (4.7) |
222,508,752 (14.9) |
224,209,892
(14.7) |
Pfizer Inc |
2,719,827 (7.6) |
115,172,458 (7.7) |
117,892,285
(7.7) |
Intercept Pharmaceuticals, Inc |
633,830 (1.8) |
84,121,144 (5.6) |
84,754,974 (5.5) |
Janssen Research & Development, LLC |
298,339 (0.8) |
83,034,668 (5.6) |
83,333,007 (5.5) |
Allergan Inc |
383,504 (1.1) |
68,615,842 (4.6) |
68,999,345
(4.5) |
Merck Sharp & Dohme Corporation |
122,994 (0.3) |
66,068,174 (4.4) |
66,191,168 (4.3) |
E.R. Squibb & Sons, LLC |
687,954 (1.9) |
54,952,751 (3.7) |
55,640,705
(3.6) |
Takeda Pharmaceuticals U.S.A., Inc |
569,071 (1.6) |
51,034,542 (3.4) |
51,603,613 (3.4) |
Shire North American Group Inc |
5,381 (0.01) |
41,687,210 (2.8) |
41,692,592 (2.7) |